{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:49:28Z","timestamp":1745390968786,"version":"3.37.3"},"reference-count":29,"publisher":"Consilium Medicum","issue":"11","license":[{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. In order to improve the diagnosis and treatment of chronic hepatitis C in the framework of this study was the awareness among general practitioner (GPs) and physicians in various districts of Chelyabinsk Oblast was assessed. Materials and methods. A continuous study of hepatitis C virus (HCV) awareness among therapists and GPs was conducted within the framework of the regional research-to-practice conference Multidisciplinary Issues of Family Medicine on May 19, 2018. 78 questionnaires have been distributed. Thus, 78 therapists from different districts of Chelyabinsk Oblast took part in the study. For these purposes, a questionnaire of 12 questions developed by Olga I. Sagalova was used. The study involved 78 therapists from different districts of Chelyabinsk Oblast. 20.52% (n=16) of respondents were from the healthcare institutions (HCI) of urban districts of Chelyabinsk Oblast, 39.74% (n=31) were from the HCIs of municipal districts of Chelyabinsk Oblast, and 39.74% (n=31) from the HCIs of the city of Chelyabinsk. Results. The survey revealed certain gaps in therapists awareness of the natural course of the disease, diagnosis, routing, the natural course of HCV infection, as well as its extrahepatic manifestations. The survey results indicate a lack of understanding among physicians and therapists of tactics for managing patients with HCV infection and emphasize the need to improve interdisciplinary interaction between infectious disease specialists, primary care doctors and doctors of other specialties including the development and implementation of an educational strategy for non-infectious disease doctors. Conclusion. The results indicate the needs to increase the level of education among doctors in the diagnosis and management of patients with HCV in accordance with guidelines and to include screening for HCV infection in the guidelines for selected chronic non-communicable diseases as part of the initial examination.<\/jats:p>","DOI":"10.26442\/00403660.2020.11.000664","type":"journal-article","created":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T05:45:35Z","timestamp":1608961535000},"page":"5-12","source":"Crossref","is-referenced-by-count":3,"title":["Hepatitis C awareness among therapists and general practitioners. Survey results"],"prefix":"10.26442","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-7342","authenticated-orcid":false,"given":"A. V.","family":"Sineglazova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-0040","authenticated-orcid":false,"given":"A. V.","family":"Sineglazova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2020,11,15]]},"reference":[{"key":"ref1","unstructured":"\u0412\u041e\u0417. \u0413\u0435\u043f\u0430\u0442\u0438\u0442 \u0421. [WHO. Hepatitis C (In Russ.)] https:\/\/www.who.int\/ru\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2018.12.009"},{"key":"ref3","unstructured":"The Viral Hepatitis Prevention Board. Viral Hepatitis. 2011;19(1). https:\/\/www.vhpb.org\/files\/html\/Meetings_and_publications\/Viral_Hepatitis_Newsletters\/vhv19n2.pdf"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"\u041f\u0438\u043c\u0435\u043d\u043e\u0432 \u041d.\u041d., \u0412\u0434\u043e\u0432\u0438\u043d \u0410.\u0412., \u041a\u043e\u043c\u0430\u0440\u043e\u0432\u0430 \u0421.\u0412. \u0438 \u0434\u0440. \u0410\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u044c \u0438 \u043f\u0435\u0440\u0441\u043f\u0435\u043a\u0442\u0438\u0432\u044b \u0432\u043d\u0435\u0434\u0440\u0435\u043d\u0438\u044f \u0432 \u0420\u043e\u0441\u0441\u0438\u0438 \u0435\u0434\u0438\u043d\u043e\u0433\u043e \u0444\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0430 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0432\u0438\u0440\u0443\u0441\u043d\u044b\u043c\u0438 \u0433\u0435\u043f\u0430\u0442\u0438\u0442\u0430\u043c\u0438 \u0412 \u0438 \u0421. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432. 2013;85(11):4-9 [Pimenov NN, Vdovin AV, Komarova SV, et al. The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia. Therapeutic Archive. 2013;85(11):4-9 (In Russ.)].","DOI":"10.1016\/j.ijrobp.2012.09.009"},{"key":"ref5","unstructured":"ITPCru. \u0414\u043e\u043b\u0433\u0438\u0435 \u043f\u0440\u043e\u0432\u043e\u0434\u044b. \u0420\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b \u043c\u043e\u043d\u0438\u0442\u043e\u0440\u0438\u043d\u0433\u0430 \u0437\u0430\u043a\u0443\u043f\u043e\u043a \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u043e\u0432 \u0434\u043b\u044f \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0433\u0435\u043f\u0430\u0442\u0438\u0442\u0430 \u0421 \u0432 \u0420\u043e\u0441\u0441\u0438\u0438 \u0432 2017 \u0433\u043e\u0434\u0443. \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433: \u041a\u043e\u0430\u043b\u0438\u0446\u0438\u044f \u043f\u043e \u0433\u043e\u0442\u043e\u0432\u043d\u043e\u0441\u0442\u0438 \u043a \u043b\u0435\u0447\u0435\u043d\u0438\u044e, 2018 [ITPCru. Long farewell. Results of monitoring the procurement of drugs for the treatment of hepatitis C in Russia in 2017. St Petersburg: Treatment Preparedness Coalition, 2018 (In Russ.)]"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.176"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2049936115585942"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.006"},{"key":"ref9","unstructured":"\u0421\u0430\u043d\u0438\u0442\u0430\u0440\u043d\u043e-\u044d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043f\u0440\u0430\u0432\u0438\u043b\u0430. \u0421\u041f 3.1.3112-13. \u041f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0430 \u0432\u0438\u0440\u0443\u0441\u043d\u043e\u0433\u043e \u0433\u0435\u043f\u0430\u0442\u0438\u0442\u0430 \u0421. 2014 [Sanitary and epidemiological rules. SP 3.1.3112-13. Prevention of viral hepatitis C. 2014 (In Russ.)]."},{"key":"ref10","unstructured":"\u041c\u0438\u043d\u0438\u0441\u0442\u0435\u0440\u0441\u0442\u0432\u043e \u0437\u0434\u0440\u0430\u0432\u043e\u043e\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u044f \u0420\u0424. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u0425\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0432\u0438\u0440\u0443\u0441\u043d\u044b\u0439 \u0433\u0435\u043f\u0430\u0442\u0438\u0442 \u0421 (\u0425\u0412\u0413\u0421) \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445. 2016 [Ministry of Health of the Russian Federation. Clinical guidelines. Chronic viral hepatitis C (HVHS) in adults. 2016 (In Russ.)]."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.026"},{"key":"ref12","unstructured":"The Boston Consulting Group. Road to elimination: barriers and best practices in hepatitis C management. 2017."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26246"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Shiffman ML, Stewart CA, Hofmann CM, et al. Chronic Infection with Hepatitis C Virus in Patients with Elevated or Persistently Normal Serum Alanine Aminotransferase Levels: Comparison of Hepatic Histology and Response to Interferon Therapy. J Infect Dis. 2000;182(6):1595-601.","DOI":"10.1086\/317612"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Inglesby TV, Rai R, Astemborski J, et al. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology. 1999;29(2):590-6.","DOI":"10.1002\/hep.510290219"},{"key":"ref16","unstructured":"\u0424\u0411\u0423\u0417 \u00ab\u0426\u0435\u043d\u0442\u0440 \u0433\u0438\u0433\u0438\u0435\u043d\u044b \u0438 \u044d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0438 \u0432 \u0427\u0435\u043b\u044f\u0431\u0438\u043d\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438\u00bb. \u0410\u043d\u0430\u043b\u0438\u0437 \u0434\u0438\u043d\u0430\u043c\u0438\u043a\u0438 \u043d\u0430\u0440\u043a\u043e\u043c\u0430\u043d\u0438\u0438, \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0430\u043b\u043a\u043e\u0433\u043e\u043b\u0438\u0437\u043c\u0430 \u0438 \u0430\u043b\u043a\u043e\u0433\u043e\u043b\u044c\u043d\u044b\u0445 \u043f\u0441\u0438\u0445\u043e\u0437\u043e\u0432 \u043f\u043e \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044f\u043c \u0441\u043e\u0446\u0438\u0430\u043b\u044c\u043d\u043e-\u0433\u0438\u0433\u0438\u0435\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u043c\u043e\u043d\u0438\u0442\u043e\u0440\u0438\u043d\u0433\u0430 \u0432 \u0427\u0435\u043b\u044f\u0431\u0438\u043d\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438 \u0437\u0430 2014 \u0433. 2014 [Federal Budgetary Healthcare Institution \u00abCenter for Hygiene and Epidemiology in Chelyabinsk Oblast\u00bb. Analysis of the dynamics of drug addiction, chronic alcoholism and alcoholic psychoses by indicators of social and hygienic monitoring in Chelyabinsk Oblast\u2019 for 2014. 2014 (In Russ.)]."},{"key":"ref17","unstructured":"Sturm D, Gurevitz SL, Davidson C, et al. Bane of Baby Boomers. Clin Rev. 2014;24(11):24-32."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/QMH.0000000000000007"},{"key":"ref19","unstructured":"\u041c\u0438\u043d\u0438\u0441\u0442\u0435\u0440\u0441\u0442\u0432\u043e \u0437\u0434\u0440\u0430\u0432\u043e\u043e\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u044f \u0427\u0435\u043b\u044f\u0431\u0438\u043d\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438. \u041e \u043c\u0430\u0440\u0448\u0440\u0443\u0442\u0438\u0437\u0430\u0446\u0438\u0438 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u043f\u0430\u0440\u0435\u043d\u0442\u0435\u0440\u0430\u043b\u044c\u043d\u044b\u043c\u0438 \u0432\u0438\u0440\u0443\u0441\u043d\u044b\u043c\u0438 \u0433\u0435\u043f\u0430\u0442\u0438\u0442\u0430\u043c\u0438 \u0432 \u0427\u0435\u043b\u044f\u0431\u0438\u043d\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438. 2016 [Ministry of Health of Chelyabinsk Oblast\u2019. On routing of adult patients with parentetal viral hepatitis in Chelyabinsk Oblast\u2019. 2016 (In Russ.)]."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):47-52.","DOI":"10.7150\/ijms.3.47"},{"key":"ref21","unstructured":"The International Liver Congress 2018 Abstract Book \u2013 EASL \u2013 The Home of Hepatology. European Association for the Study of the Liver. https:\/\/easl.eu\/publication\/the-international-liver-congress-2018-abstract-book\/"},{"key":"ref22","unstructured":"Hepatitis C. Questions and Answers. CDC. https:\/\/www.cdc.gov\/hepatitis\/hcv\/cfaq.htm"},{"key":"ref23","unstructured":"\u041a\u0430\u043f\u0440\u0438\u043d \u0410.\u0414., \u0421\u0442\u0430\u0440\u0438\u043d\u0441\u043a\u0438\u0439 \u0412.\u0412., \u041f\u0435\u0442\u0440\u043e\u0432\u0430 \u0413.\u0412. \u0417\u043b\u043e\u043a\u0430\u0447\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0435 \u043d\u043e\u0432\u043e\u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f \u0432 \u0420\u043e\u0441\u0441\u0438\u0438 \u0432 2017 \u0433\u043e\u0434\u0443. 2018 [Kaprin AD, Starinskii VV, Petrova GV. Malignant neoplasms in Russia in 2017. 2018 (In Russ.)]."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2017.00067"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw035"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2017.03.007"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6150861"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23561"},{"key":"ref29","unstructured":"Hepatitis C: Common, Deadly, and Curable. https:\/\/www.bcg.com\/publications\/2017\/health-care-payers-providers-hepatitis-c-common-deadly-curable.aspx"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/56910\/40096","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/56910\/40096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T09:35:05Z","timestamp":1670578505000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/56910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,15]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,15]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2020.11.000664","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"type":"electronic","value":"2309-5342"},{"type":"print","value":"0040-3660"}],"subject":[],"published":{"date-parts":[[2020,11,15]]}}}